InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Cue Biopharma, Inc.

CUE Clue Score62
United States Fiscal year ends December CIK 0001645460
$27.66 +23.87% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $27.66 +113.59% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 2 Jan 2018. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Operating income−23.2Net income−23.2Fiscal year 2018Revenue1.1Operating income−38.7Net income−39.0Fiscal year 2019Revenue3.5 +202.7%Operating income−36.8Net income−36.7Fiscal year 2020Revenue3.2 −8.8%Operating income−45.0Net income−44.8Fiscal year 2021Revenue14.9 +373.7%Operating income−43.7Net income−44.2EPS, diluted−1.41Fiscal year 2022Revenue1.2 −91.7%Operating income−53.2Net income−53.0EPS, diluted−1.49Fiscal year 2023Revenue5.5 +341.0%Operating income−52.1Net income−50.7EPS, diluted−1.11Fiscal year 2024Revenue9.3 +69.2%Operating income−41.5Net income−40.7EPS, diluted−0.72Fiscal year 2025Revenue27.5 +195.7%Operating income−26.6Net income−26.6EPS, diluted−0.28
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue n/a 1.1 3.5 3.2 14.9 1.2 5.5 9.3 27.5
Growth +202.7% −8.8% +373.7% −91.7% +341.0% +69.2% +195.7%
Operating income −23.2 −38.7 −36.8 −45.0 −43.7 −53.2 −52.1 −41.5 −26.6
Net income −23.2 −39.0 −36.7 −44.8 −44.2 −53.0 −50.7 −40.7 −26.6
Growth
EPS, diluted n/a n/a n/a n/a −1.41 −1.49 −1.11 −0.72 −0.28

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2017Fiscal year 2018Operating margin−3,386.7%Net margin−3,411.5%Free cash flow margin−2,473.8%Fiscal year 2019Operating margin−1,063.2%Net margin−1,061.2%Free cash flow margin−891.9%Fiscal year 2020Operating margin−1,428.0%Net margin−1,419.8%Free cash flow margin−1,049.0%Fiscal year 2021Operating margin−292.6%Net margin−295.6%Free cash flow margin−266.0%Fiscal year 2022Operating margin−4,275.1%Net margin−4,257.8%Free cash flow margin−3,371.6%Fiscal year 2023Operating margin−949.9%Net margin−924.1%Free cash flow margin−727.9%Fiscal year 2024Operating margin−446.9%Net margin−438.0%Free cash flow margin−391.9%Fiscal year 2025Operating margin−96.7%Net margin−96.9%Free cash flow margin−79.6%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin n/a −3,386.7% −1,063.2% −1,428.0% −292.6% −4,275.1% −949.9% −446.9% −96.7%
Net margin n/a −3,411.5% −1,061.2% −1,419.8% −295.6% −4,257.8% −924.1% −438.0% −96.9%
Free cash flow margin n/a −2,473.8% −891.9% −1,049.0% −266.0% −3,371.6% −727.9% −391.9% −79.6%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow−12.1Capital expenditure−1.0Free cash flow−13.2Fiscal year 2018Operating cash flow−26.4Capital expenditure−1.9Free cash flow−28.3Fiscal year 2019Operating cash flow−30.8Capital expenditure−0.0Free cash flow−30.8Buybacks−0.1Fiscal year 2020Operating cash flow−32.5Capital expenditure−0.6Free cash flow−33.1Buybacks−0.3Fiscal year 2021Operating cash flow−38.8Capital expenditure−0.9Free cash flow−39.8Buybacks−0.8Fiscal year 2022Operating cash flow−41.8Capital expenditure−0.2Free cash flow−42.0Buybacks−0.2Fiscal year 2023Operating cash flow−40.0Capital expenditure0.0Free cash flow−40.0Buybacks0.0Fiscal year 2024Operating cash flow−36.3Capital expenditure−0.1Free cash flow−36.4Fiscal year 2025Operating cash flow−21.7Capital expenditure−0.2Free cash flow−21.9
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −12.1 −26.4 −30.8 −32.5 −38.8 −41.8 −40.0 −36.3 −21.7
Capital expenditure −1.0 −1.9 −0.0 −0.6 −0.9 −0.2 0.0 −0.1 −0.2
Free cash flow −13.2 −28.3 −30.8 −33.1 −39.8 −42.0 −40.0 −36.4 −21.9
Growth
Buybacks n/a n/a −0.1 −0.3 −0.8 −0.2 0.0 n/a n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2017Cash63.5Shareholders’ equity61.6Fiscal year 2018Cash20.8Shareholders’ equity34.0Fiscal year 2019Cash44.3Shareholders’ equity54.6Fiscal year 2020Cash74.9Shareholders’ equity78.9Fiscal year 2021Cash64.4Total debt0.0Net cash (debt)64.4Shareholders’ equity65.5Debt to equity0.00Fiscal year 2022Cash51.6Total debt10.0Net cash (debt)41.6Shareholders’ equity65.7Debt to equity0.15Fiscal year 2023Cash48.5Total debt8.2Net cash (debt)40.3Shareholders’ equity37.1Debt to equity0.22Fiscal year 2024Cash22.5Total debt0.0Net cash (debt)22.5Shareholders’ equity17.5Debt to equity0.00Fiscal year 2025Cash27.1Shareholders’ equity26.4
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 63.5 20.8 44.3 74.9 64.4 51.6 48.5 22.5 27.1
Total debt n/a n/a n/a n/a 0.0 10.0 8.2 0.0 n/a
Net cash (debt) n/a n/a n/a n/a 64.4 41.6 40.3 22.5 n/a
Shareholders’ equity 61.6 34.0 54.6 78.9 65.5 65.7 37.1 17.5 26.4
Debt to equity n/a n/a n/a n/a 0.00 0.15 0.22 0.00 n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025† 31 Dec 2025
Revenue and profit
n/a 1.1 3.5 3.2 14.9 1.2 5.5 9.3 27.5
Growth +202.7% −8.8% +373.7% −91.7% +341.0% +69.2% +195.7%
18.9 28.5 27.5 33.5 41.3 38.6 40.8 36.3 37.7
4.3 11.3 12.7 14.7 17.3 16.2 16.7 14.6 16.2
−23.2 −38.7 −36.8 −45.0 −43.7 −53.2 −52.1 −41.5 −26.6
Growth
−23.2 −38.2 −36.3 −44.6 −43.7 −53.0 n/a n/a n/a
n/a 0.8 0.4 0.2 0.5 0.0 n/a 0.0 0.5
−23.2 −39.0 −36.7 −44.8 −44.2 −53.0 −50.7 −40.7 −26.6
Growth
Per share
n/a n/a n/a n/a −1.41 −1.49 −1.11 −0.72 −0.28
n/a n/a n/a n/a −1.41 −1.49 −1.11 −0.72 −0.28
Growth
n/a n/a n/a n/a 31.3 35.6 45.8 56.3 94.7
n/a n/a n/a n/a 31.3 35.6 45.8 56.3 94.7
Growth +13.9% +28.3% +23.1% +68.2%

† The diluted share count jumps at 2025, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • Revenue grew 54.2% a year over five years.
  • Operating margin is up 1,331.3 points on five years ago, at -96.7%.
  • A net loss in 9 of 9 years on file.